Matches in Nanopublications for { ?s ?p "[Generalized alterations in beta-adrenergic signalling, including betaARK1, could be a major contributory factor in the development of LVH in hypertension, and the concentration of betaARK1 in lymphocytes can reflect the development of LVH in a patient with hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_assertion description "[Generalized alterations in beta-adrenergic signalling, including betaARK1, could be a major contributory factor in the development of LVH in hypertension, and the concentration of betaARK1 in lymphocytes can reflect the development of LVH in a patient with hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance.
- assertion description "[Generalized alterations in beta-adrenergic signalling, including betaARK1, could be a major contributory factor in the development of LVH in hypertension, and the concentration of betaARK1 in lymphocytes can reflect the development of LVH in a patient with hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Generalized alterations in beta-adrenergic signalling, including betaARK1, could be a major contributory factor in the development of LVH in hypertension, and the concentration of betaARK1 in lymphocytes can reflect the development of LVH in a patient with hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP227388.RAsSxTWb6N14Pm7dnnCDg0tRJhBEy_kx6ak4hG7tCSpJE130_assertion description "[Generalized alterations in beta-adrenergic signalling, including betaARK1, could be a major contributory factor in the development of LVH in hypertension, and the concentration of betaARK1 in lymphocytes can reflect the development of LVH in a patient with hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227388.RAsSxTWb6N14Pm7dnnCDg0tRJhBEy_kx6ak4hG7tCSpJE130_provenance.
- NP440775.RApTsrNCYRmSp7tGG4GdP-2JOCzTRNDgX_e7VOpHrAzs8130_assertion description "[Generalized alterations in beta-adrenergic signalling, including betaARK1, could be a major contributory factor in the development of LVH in hypertension, and the concentration of betaARK1 in lymphocytes can reflect the development of LVH in a patient with hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440775.RApTsrNCYRmSp7tGG4GdP-2JOCzTRNDgX_e7VOpHrAzs8130_provenance.
- NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_assertion description "[Generalized alterations in beta-adrenergic signalling, including betaARK1, could be a major contributory factor in the development of LVH in hypertension, and the concentration of betaARK1 in lymphocytes can reflect the development of LVH in a patient with hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_provenance.
- NP440774.RAJZqIbrdM_5ErrQYkMpxkg1O7zn1RyacihOf1sShgPn4130_assertion description "[Generalized alterations in beta-adrenergic signalling, including betaARK1, could be a major contributory factor in the development of LVH in hypertension, and the concentration of betaARK1 in lymphocytes can reflect the development of LVH in a patient with hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440774.RAJZqIbrdM_5ErrQYkMpxkg1O7zn1RyacihOf1sShgPn4130_provenance.